Donald Notman, Chief Operating Officer at Ocular Therapeutix, sold OCUL on Aug 31, 2026

Data as of Oct 16

▼ SELL$11.3K1,099 shares at $10.24Donald Notman Chief Operating OfficerOCUL Ocular Therapeutix, Inc

Watch OCUL

Traded: Aug 31, 2026
Disclosed: Sep 2, 2026
Filed: 2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

OCULSimilar stocks (S&P 500 (SPY)), rebased to OCUL's price on the disclosure day

OCUL since disclosure

−37.0%

after the sale

Similar stocks (SPY) since disclosure

−0.2%

S&P 500 (SPY)

Change in closing price from Sep 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on OCUL →